Liu, L., Erickson, N. T., Ricard, I., von Weikersthal, L. F., Lerch, M. M., Decker, T., Kiani, A., Kaiser, F., Heintges, T., Kahl, C., Kullmann, F., Scheithauer, W., Link, H., Hoffkes, H. G., Moehler, M., Gesenhues, A. B., Theurich, S., Michl, M., Modest, D. P., Algul, H., Stintzing, S., Heinemann, V. and Holch, J. W. (2022). "Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)." Int J Cancer 150(1): 112-123

Pichler, T., Rohrmoser, A., Letsch, A., Westphalen, C. B., Keilholz, U., Heinemann, V., Lamping, M., Jost, P. J., Riedmann, K., Herschbach, P. and Goerling, U. (2021). "Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine?" Support Care Cancer 29(4): 2171-2178.

Weigl, K., Tikk, K., Hoffmeister, M., Hampe, J., Igel, S., Kolligs, F., Klug, S. J., Mansmann, U., Muller, O., Nagel, J. M., Pichler, M., Schwab, M., Schweigler, D., Stephan, A. M., De Toni, E. N. and Brenner, H. (2020). "Prevalence of a First-Degree Relative With Colorectal Cancer and Uptake of Screening Among Persons 40 to 54 Years Old." Clin Gastroenterol Hepatol 18(11): 2535-2543 e2533.

Rohrmoser, A., Pichler, T., Letsch, A., Westphalen, C. B., Keilholz, U., Heinemann, V., Goerling, U. and Herschbach, P. (2020). "Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative study." Psychooncology 29(2): 423-429.

Hermelink, K., Buhner, M., Sckopke, P., Neufeld, F., Kaste, J., Voigt, V., Munzel, K., Wuerstlein, R., Ditsch, N., Hellerhoff, K., Rjosk-Dendorfer, D., Braun, M., von Koch, F. E., Hartl, K., Hasmuller, S., Bauerfeind, I., Debus, G., Herschbach, P., Mahner, S. and Harbeck, N. (2017). "Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients." J Natl Cancer Inst 109(10).

Calais, J., Ceci, F., Eiber, M., Hope, T. A., Hofman, M. S., Rischpler, C., Bach-Gansmo, T., Nanni, C., Savir-Baruch, B., Elashoff, D., Grogan, T., Dahlbom, M., Slavik, R., Gartmann, J., Nguyen, K., Lok, V., Jadvar, H., Kishan, A. U., Rettig, M. B., Reiter, R. E., Fendler, W. P. and Czernin, J. (2019). "(18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial." Lancet Oncol 20(9): 1286-1294.

Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P. A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., Zecha, J., Reiter, K., Qiao, H., Helm, D., Koch, H., Schoof, M., Canevari, G., Casale, E., Depaolini, S. R., Feuchtinger, A., Wu, Z., Schmidt, T., Rueckert, L., Becker, W., Huenges, J., Garz, A. K., Gohlke, B. O., Zolg, D. P., Kayser, G., Vooder, T., Preissner, R., Hahne, H., Tonisson, N., Kramer, K., Gotze, K., Bassermann, F., Schlegl, J., Ehrlich, H. C., Aiche, S., Walch, A., Greif, P. A., Schneider, S., Felder, E. R., Ruland, J., Medard, G., Jeremias, I., Spiekermann, K. and Kuster, B. (2017). "The target landscape of clinical kinase drugs." Science 358(6367).

Renz, B. W., Tanaka, T., Sunagawa, M., Takahashi, R., Jiang, Z., Macchini, M., Dantes, Z., Valenti, G., White, R. A., Middelhoff, M. A., Ilmer, M., Oberstein, P. E., Angele, M. K., Deng, H., Hayakawa, Y., Westphalen, C. B., Werner, J., Remotti, H., Reichert, M., Tailor, Y. H., Nagar, K., Friedman, R. A., Iuga, A. C., Olive, K. P. and Wang, T. C. (2018). "Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness." Cancer Discov 8(11): 1458-1473.

Mueller, S., Engleitner, T., Maresch, R., Zukowska, M., Lange, S., Kaltenbacher, T., Konukiewitz, B., Ollinger, R., Zwiebel, M., Strong, A., Yen, H. Y., Banerjee, R., Louzada, S., Fu, B., Seidler, B., Gotzfried, J., Schuck, K., Hassan, Z., Arbeiter, A., Schonhuber, N., Klein, S., Veltkamp, C., Friedrich, M., Rad, L., Barenboim, M., Ziegenhain, C., Hess, J., Dovey, O. M., Eser, S., Parekh, S., Constantino-Casas, F., de la Rosa, J., Sierra, M. I., Fraga, M., Mayerle, J., Kloppel, G., Cadinanos, J., Liu, P., Vassiliou, G., Weichert, W., Steiger, K., Enard, W., Schmid, R. M., Yang, F., Unger, K., Schneider, G., Varela, I., Bradley, A., Saur, D. and Rad, R. (2018). "Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes." Nature 554(7690): 62-68.

Lesch, S., Blumenberg, V., Stoiber, S., Gottschlich, A., Ogonek, J., Cadilha, B. L., Dantes, Z., Rataj, F., Dorman, K., Lutz, J., Karches, C. H., Heise, C., Kurzay, M., Larimer, B. M., Grassmann, S., Rapp, M., Nottebrock, A., Kruger, S., Tokarew, N., Metzger, P., Hoerth, C., Benmebarek, M. R., Dhoqina, D., Grunmeier, R., Seifert, M., Oener, A., Umut, O., Joaquina, S., Vimeux, L., Tran, T., Hank, T., Baba, T., Huynh, D., Megens, R. T. A., Janssen, K. P., Jastroch, M., Lamp, D., Ruehland, S., Di Pilato, M., Pruessmann, J. N., Thomas, M., Marr, C., Ormanns, S., Reischer, A., Hristov, M., Tartour, E., Donnadieu, E., Rothenfusser, S., Duewell, P., Konig, L. M., Schnurr, M., Subklewe, M., Liss, A. S., Halama, N., Reichert, M., Mempel, T. R., Endres, S. and Kobold, S. (2021). "T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours." Nat Biomed Eng 5(11): 1246-1260.

Stenger, D., Stief, T. A., Kaeuferle, T., Willier, S., Rataj, F., Schober, K., Vick, B., Lotfi, R., Wagner, B., Grunewald, T. G. P., Kobold, S., Busch, D. H., Jeremias, I., Blaeschke, F. and Feuchtinger, T. (2020). "Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR." Blood 136(12): 1407-1418.

Mulazzani, M., Frassle, S. P., von Mucke-Heim, I., Langer, S., Zhou, X., Ishikawa-Ankerhold, H., Leube, J., Zhang, W., Dotsch, S., Svec, M., Rudelius, M., Dreyling, M., von Bergwelt-Baildon, M., Straube, A., Buchholz, V. R., Busch, D. H. and von Baumgarten, L. (2019). "Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice." Proc Natl Acad Sci U S A 116(48): 24275-24284.

Wartewig, T., Kurgyis, Z., Keppler, S., Pechloff, K., Hameister, E., Ollinger, R., Maresch, R., Buch, T., Steiger, K., Winter, C., Rad, R. and Ruland, J. (2017). "PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis." Nature 552(7683): 121-125.

Nasseh, D., Schneiderbauer, S., Lange, M., Schweizer, D., Heinemann, V., Belka, C., Cadenovic, R., Buysse, L., Erickson, N., Mueller, M., Kortuem, K., Niyazi, M., Marschner, S. and Fey, T. (2020). "Optimizing the Analytical Value of Oncology-Related Data Based on an In-Memory Analysis Layer: Development and Assessment of the Munich Online Comprehensive Cancer Analysis Platform." J Med Internet Res 22(4): e16533

Pan, C., Schoppe, O., Parra-Damas, A., Cai, R., Todorov, M. I., Gondi, G., von Neubeck, B., Bogurcu-Seidel, N., Seidel, S., Sleiman, K., Veltkamp, C., Forstera, B., Mai, H., Rong, Z., Trompak, O., Ghasemigharagoz, A., Reimer, M. A., Cuesta, A. M., Coronel, J., Jeremias, I., Saur, D., Acker-Palmer, A., Acker, T., Garvalov, B. K., Menze, B., Zeidler, R. and Erturk, A. (2019). "Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body." Cell 179(7): 1661-1676 e1619.